Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.53
(
-1.22%
)
Bitcoin
74,532.25
(
0.91%
)
News Focus
News Focus
Post# of 517434
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27740
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: falconer66a post# 301050

Sunday, 02/28/2021 10:42:53 AM

Sunday, February 28, 2021 10:42:53 AM

Post# of 517434

will greatly facilitate or prompt FDA approval of blarcamesine for Parkinson's disease dementia.


By prompt, I am assuming you mean after a positive readout from the planned P3 PDD trial perhaps some time in 2023?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News